| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 0Y70779M1F |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Vesicle-associated membrane protein 2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sialorrhea | 3 | D012798 | ClinicalTrials |
| Dementia | 2 | D003704 | ClinicalTrials |
| Hyperhidrosis | 2 | D006945 | ClinicalTrials |
| Muscle Spasticity | 2 | D009128 | ClinicalTrials |
| Skin Ulcer | 2 | D012883 | ClinicalTrials |
| Carpal Tunnel Syndrome | 2 | D002349 | ClinicalTrials |
| Atrial Fibrillation | 2 | D001281 | ClinicalTrials |
| Cerebral Palsy | 1 | D002547 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108710 |
| FDA SRS | 0Y70779M1F |
CONTENTS